The Impact of Private Equity Investment on Strategic Decision-Making in Artificial Intelligence Healthcare Companies: A Case Study of Keya Medical

Naying Yu

doi:10.54254/2754-1169/2026.NJ29579

Advances in Economics, Management and Political SciencesOpen access

The Impact of Private Equity Investment on Strategic Decision-Making in Artificial Intelligence Healthcare Companies: A Case Study of Keya Medical

Research Article

Open Access

The Impact of Private Equity Investment on Strategic Decision-Making in Artificial Intelligence Healthcare Companies: A Case Study of Keya Medical

Naying Yu ^1*

¹ Central University of Finance and Economics

^*Corresponding author: 2024311716@email.cufe.edu.cn

Published on 19 November 2025

AEMPS Vol.242

ISSN (Print): 2754-1177

ISSN (Online): 2754-1169

ISBN (Print): 978-1-80590-555-4

ISBN (Online): 978-1-80590-556-1

Download Cover

Abstract

The scale of China's health consumption market is accelerating. The Artificial Intelligence(AI) healthcare industry is rapidly emerging, driving the continuous development of the industry. As a high-tech and highly uncertain emerging industry, the AI healthcare industry requires a large amount of external funding support in the early stages, so private equity needs to be introduced to help the growth of enterprises. This article studied the impact of the introduction of private equity on the strategic decision-making of companies in the AI healthcare sector. The study adopted a longitudinal single case study method and selected Koya Medical Company as the research object. By comparing the changes in strategic focus, product development direction, recruitment of personnel, and Initial Public Offering (IPO) process before and after introducing private equity, it was found that after introducing private equity, the company's strategic focus will shift from technology research and development to commercialization, with an increase in applied product research and development, large-scale construction of commercial teams, and significantly accelerated IPO process.

Keywords:

Private equity, AI healthcare, healthcare, strategic decision

View PDF

References

[1]. Liu, J. J. (2023) Analysis and Risk Control of Biomedical and Health Industry Investment. Technology and Economic Market 3, 10-12.

[2]. Mo, L. (2025) AI in Healthcare Becomes a New Blue Ocean for Global Investment. Financial Times 8, 36-44.

[3]. Wang, X. N. & Yan, L. (2025) Research on the Motivation and Post-Investment Performance of Introducing Private Equity Investment. Journal of Hubei University of Economics (Humanities and Social Sciences), 22, 55-58.

[4]. Zhang, Y. L. (2024) The Role of Private Equity Investment in the Financing of Technology-Based Enterprises. International Business Accounting 21, 88-91.

[5]. Nuchao, L., Ying, W. & Li, H. (2023) Does Private Equity Investment Influence Enterprise Innovation Strategy?. Finance Research Letters, 58, 104-159.

[6]. Huang, J. (2023) Research on the Impact of Private Equity Investment on Corporate Value and Performance. China Circulation Economy 5, 93-96.

[7]. Wu, J. Z. & Jiang, S. (2018) Private Equity Participation, Corporate Social Responsibility, and Profitability: Evidence From the NEEQ Market. Journal of Chongqing Technology and Business University (Social Sciences Edition), 35, 40-48.

[8]. Charles, K., Luciano, R., Andrea, M. et al. (2023) The Tradeoff Between Private Equity Sponsorship, Board Centrality, and Experience as Credible Signals for IPO Performance. Management and Organization Review, 19, 462-497.

[9]. Xu, H. H. (2024) Discussion on the Current Situation and Development Direction of Private Equity Investment Exit Mechanisms in China. Financial Community 35, 69-71.

[10]. Yang, S. & Du, Y. (2025) Private Equity and the Risk-Taking of Small and Medium-Sized Enterprises. Finance Research Letters, 85, 108-194.

References

[1]. Liu, J. J. (2023) Analysis and Risk Control of Biomedical and Health Industry Investment. Technology and Economic Market 3, 10-12.

[2]. Mo, L. (2025) AI in Healthcare Becomes a New Blue Ocean for Global Investment. Financial Times 8, 36-44.

[4]. Zhang, Y. L. (2024) The Role of Private Equity Investment in the Financing of Technology-Based Enterprises. International Business Accounting 21, 88-91.

[5]. Nuchao, L., Ying, W. & Li, H. (2023) Does Private Equity Investment Influence Enterprise Innovation Strategy?. Finance Research Letters, 58, 104-159.

[6]. Huang, J. (2023) Research on the Impact of Private Equity Investment on Corporate Value and Performance. China Circulation Economy 5, 93-96.

[9]. Xu, H. H. (2024) Discussion on the Current Situation and Development Direction of Private Equity Investment Exit Mechanisms in China. Financial Community 35, 69-71.

[10]. Yang, S. & Du, Y. (2025) Private Equity and the Risk-Taking of Small and Medium-Sized Enterprises. Finance Research Letters, 85, 108-194.

Cite this article

Yu,N. (2025). The Impact of Private Equity Investment on Strategic Decision-Making in Artificial Intelligence Healthcare Companies: A Case Study of Keya Medical. Advances in Economics, Management and Political Sciences,242,13-18.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

About volume

Volume title: Proceedings of CONF-BPS 2026 Symposium: Sustainability Transitions and Regional Economic Restructuring in New Contexts

ISBN: 978-1-80590-555-4(Print) / 978-1-80590-556-1(Online)

Editor: Canh Thien Dang, Xiaohui Hu

Conference website: https://www.confbps.org/Nanjing.html

Conference date: 9 January 2026

Series: Advances in Economics, Management and Political Sciences

Volume number: Vol.242

ISSN: 2754-1169(Print) / 2754-1177(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).